Delta-Fly Pharma, Inc. (4598.T)

JPY 487.0

(1.67%)

Annual Income Statements

(In JPY)
Breakdown 2024 2023 2022 2021 2020
Revenue - - 300 Million 300 Million 100 Million
Cost of Revenue 1.51 Million 1.63 Million - - -
Gross Profit -1.51 Million -1.63 Million 300 Million 300 Million 100 Million
Operating Expenses 1.4 Billion 1.31 Billion 1.26 Billion 1.15 Billion 1.65 Billion
Selling, General and Administrative Expenses 284.84 Million 303.98 Million 320.67 Million 285.31 Million 218 Million
Research and Development Expenses 1.11 Billion 1.01 Billion 940.78 Million 866.92 Million 1.39 Billion
Other Expenses 56 Million 32 Thousand 120 Thousand 211 Thousand -30.61 Million
Cost and Expenses 1.4 Billion 1.31 Billion 1.26 Billion 1.15 Billion 1.65 Billion
Operating Income -1.4 Billion -1.31 Billion -961.46 Million -852.23 Million -1.54 Billion
Interest Expense - - 1.87 Million 43 Thousand 170 Thousand
Income Tax Expense 2.5 Million 3.02 Million 3.23 Million 3.21 Million 3 Million
Earnings before Tax -1.42 Billion -1.32 Billion -964.06 Million -859.37 Million -1.55 Billion
Net Income -1.42 Billion -1.32 Billion -967.3 Million -862.58 Million -1.55 Billion
Earnings Per Share Basic -198.72 -234.51 -178.58 -187.34 -348.14
Earnings Per Share Diluted -198.72 -234.51 -178.58 -187.34 -348.14
Weighted Average Shares Outstanding 7.19 Million 5.66 Million 5.41 Million 4.6 Million 4.46 Million
Weighted Average Shares Outstanding (Diluted) 7.19 Million 5.66 Million 5.41 Million 4.6 Million 4.46 Million
Gross Margin - - 1.00 1.00 1.00
EBIT Margin - - -3.20 -2.86 -15.44
Profit Margin - - -3.22 -2.88 -15.55
EBITDA -1.4 Billion -1.32 Billion -960 Million -857.32 Million -1.55 Billion
Earnings Before Tax Margin - - -3.20 -2.84 -15.45

Income Statement Charts